Exscientia is now Recursion

Stay up to date at www.Recursion.com

Precision Medicine

First integrated system to demonstrate improved clinical outcomes in oncology using live patient tissue and the power of AI.

Testing directly on viable human tissue, we also analyse data at the single cell level. In the landmark EXALT-1 clinical study, our platform demonstrated for the first time that functional precision-oncology can improve patient outcomes in a prospective interventional trial.

Human Tissue

Interrogating activities directly in viable human tissue samples allows us to generate deep, clinically relevant insights into which molecules will deliver the most treatment benefit.

Single Cell

Exploring response at single cell resolution allows us to even distinguish on-target from off-target response in complex tissues.

AI Analysis

Powered by AI and primarily focusing on potential benefit for the patient, we are pioneering new approaches in precision medicine. This approach has demonstrated, for the first time, that functional precision oncology can improve patient outcomes in a prospective interventional trial.

EXALT-1

Progression Free Survival